Paralyzed Musician Creates Songs Using Brain Implant Technology

What Happened Dr. Galen Buckwalter has achieved what was once pure science fiction: creating music directly from brain signals. In 2024, Buckwalter underwent surgery to implant six Utah arrays—containing 64 microelectrodes each—across multiple brain regions including motor, sensory, and frontal cortices. Most remarkably, his implant includes the world’s first chronic placement inside the dorsolateral prefrontal cortex, a brain region crucial for reasoning and language. A Caltech graduate student developed a specialized algorithm that translates Buckwalter’s thoughts into musical tones.

Read more →

China Approves First Commercial Brain Chip for Paralyzed Patients

What Happened Neuracle Medical Technology received regulatory approval to commercially sell its brain-computer interface (BCI) device designed to treat hand paralysis caused by spinal cord injuries. The implant detects brain signals when patients think about moving their hands, then translates these neural patterns through software to control an external robotic glove. This approval represents a significant regulatory milestone—while companies like Neuralink, Synchron, and European competitors continue conducting clinical trials, China has authorized the first BCI device for direct sale to patients and healthcare providers.

Read more →

First 5-Year Brain Implant User Controls Smart Home with Thoughts

What Happened Rodney Gorham represents a breakthrough in brain-computer interface (BCI) technology, having used Synchron’s neural implant system for five continuous years—longer than anyone else with this type of device. Diagnosed with ALS, Gorham received the Stentrode implant through a minimally invasive procedure that placed the device over his motor cortex via blood vessels, avoiding the need for open brain surgery. The system allows Gorham to control a wide range of digital devices using only his thoughts.

Read more →

China Races Ahead in Brain-Computer Interface Race

What Happened China has achieved a significant milestone in brain-computer interface (BCI) technology by completing its first fully implanted wireless BCI trial—only the second such achievement globally. The breakthrough allows paralyzed patients to control computers and devices directly through neural signals without requiring external hardware connections. NeuroXess, one of China’s leading BCI companies, is conducting the country’s first high-throughput implantable BCI clinical trial in partnership with Shanghai’s Huashan Hospital. Meanwhile, competitor Gestala expects to launch its first-generation BCI products by the third quarter of 2026.

Read more →